Posted by Michael Wonder on 14 May 2024
Baxter secures FDA approval of Clinolipid (lipid injectable emulsion) neonatal and paediatric indication
13 May 2024 - Expanded indication demonstrates Baxter’s continued commitment to meeting the diverse nutritional needs of patients, from preterm neonates to adults.
Baxter today announced US FDA approval of an expanded indication for Clinolipid (lipid injectable emulsion) to be used in paediatric patients, including preterm and term neonates.
